Early research (Phase 1)Looking for participantsNCT07838220What this trial is testingIBI3016 in Japanese ParticipantsWho this might be right forHypertension Innovent Biologics (Suzhou) Co. Ltd. 30
Testing effectiveness (Phase 2)Looking for participantsNCT07671924What this trial is testingThe Effect of Nalbuphine Extended-Release (NAL ER) on Cough in Participants With Refractory Chronic Cough (RCC)Who this might be right forRefractory Chronic Cough Trevi Therapeutics 100
Large-scale testing (Phase 3)Active Not RecruitingNCT06847724What this trial is testingComparative PK, PD, Efficacy, and Safety Assessment of the Proposed Ocrelizumab Biosimilar CYB704 and Ocrevus in Participants With Relapsing Multiple SclerosisWho this might be right forRelapsing Multiple Sclerosis Sandoz 183
Testing effectiveness (Phase 2)Looking for participantsNCT03020979What this trial is testingA Clinical Trial With Apatinib for Subjects With Refractory Malignant AscitesWho this might be right forMalignant AscitesApatinib The First Affiliated Hospital of Bengbu Medical University 120
Early research (Phase 1)Study completedNCT02877979What this trial is testingEvaluate the Safety & Assess Local and Systemic PK of DS003 Vaginal Tablets Administered to Healthy HIV-negative WomenWho this might be right forHIV International Partnership for Microbicides, Inc. 36
Large-scale testing (Phase 3)Study completedNCT03726879What this trial is testingEvaluate the Efficacy and Safety Of Atezolizumab or Placebo in Combination With Neoadjuvant Doxorubicin + Cyclophosphamide Followed By Paclitaxel + Trastuzumab + Pertuzumab In Early Her2-Positive Breast CancerWho this might be right forBreast Cancer Hoffmann-La Roche 454
Testing effectiveness (Phase 2)Study completedNCT03201562What this trial is testingA Single-Center, Double-Masked Evaluation of the Efficacy and Safety of PRX-100 in the Treatment of Early to Moderate PresbyopiaWho this might be right forPresbyopia LENZ Therapeutics, Inc 58
Large-scale testing (Phase 3)Study completedNCT04218162What this trial is testingLasmiditan Compared to Placebo in the Acute Treatment of Migraine in KoreanWho this might be right forAcute Migraine IlDong Pharmaceutical Co Ltd 294
Early research (Phase 1)Looking for participantsNCT06607003What this trial is testingInduced Blood-Stage Malaria in Healthy Malaria-Naive Adults to Assess the Safety and Infectivity of Plasmodium Vivax Challenge Agent and Evaluate Transmission in Mosquito Feeding AssaysWho this might be right forMalaria National Institute of Allergy and Infectious Diseases (NIAID) 300
Early research (Phase 1)Study completedNCT02531685What this trial is testingPhase 1 Study of dmLT ID Vaccination in Healthy AdultsWho this might be right forGastroenteritis Escherichia Coli National Institute of Allergy and Infectious Diseases (NIAID) 100
Testing effectiveness (Phase 2)Ended earlyNCT01679678What this trial is testingA Study, Performed in Subjects With Post Traumatic-post Surgical ,Venus Insufficiency and Diabetic Hard to Heal/Chronic Wounds, to Evaluate the Safety and Efficacy of PolyHeal-2 Versus PolyHeal in Once Daily RegimenWho this might be right forSurgical Wound Dehiscence MediWound Ltd 15
Early research (Phase 1)Study completedNCT06693908What this trial is testingEvaluate the Activity, and Safety of Vixarelimab in Participants With Moderate to Severe Active Ulcerative ColitisWho this might be right forModerate to Severe Ulcerative Colitis Genentech, Inc. 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07754825What this trial is testingA Phase II Clinical Study of LT3001 for Injection in the Treatment of Acute Ischemic StrokeWho this might be right forAcute Ischemic Stroke Shanghai Pharmaceuticals Holding Co., Ltd 300
Large-scale testing (Phase 3)Active Not RecruitingNCT06291376What this trial is testingStudy of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)Who this might be right forImmunoglobulin A NephropathyIgAN Alexion Pharmaceuticals, Inc. 579
Testing effectiveness (Phase 2)Looking for participantsNCT06197568What this trial is testingProof of Concept Study of Vaginal AZU-101 in Vulvovaginal Atrophy in Postmenopausal WomenWho this might be right forVulvo Vaginal Atrophy (VVA) Azure Biotech Inc. 90
Early research (Phase 1)Study completedNCT00006368What this trial is testingYttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent CancerWho this might be right forBrain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more Novartis Pharmaceuticals 60
Large-scale testing (Phase 3)Ended earlyNCT03710291What this trial is testingEvaluation of Effect of TRC101 on Progression of Chronic Kidney Disease in Subjects With Metabolic AcidosisWho this might be right forMetabolic AcidosisChronic Kidney Disease Tricida, Inc. 1,480
Early research (Phase 1)WithdrawnNCT04041674What this trial is testingEvaluating the Safety and Immunogenicity of a Prime-boost Vaccine Regimen of GEO-D02 DNA and MVA/HIV62B With and Without B63521^11 gp120 and IHV01 gp120 Env Proteins in Healthy, HIV-uninfected Adult ParticipantsWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)Study completedNCT00044018What this trial is testingCDC-501 Therapy in Relapsed or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Celgene 102
Large-scale testing (Phase 3)UnknownNCT02130882What this trial is testingStudy to Evaluate Safety and Efficacy of Benralizumab in Subjects With Hypereosinophilic SyndromeWho this might be right forRespiratory System AgentsAnti-Asthmatic AgentsHematologic Diseases+2 more National Institute of Allergy and Infectious Diseases (NIAID) 20